| Peritoneal and Retroperitoneal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 142show all (up to 200) |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 89 trials (22 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 82 trials (22 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 82 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 60 trials (23 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 35 trials (17 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 33 trials (8 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 32 trials (8 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 27 trials (11 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 26 trials (4 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 24 trials (16 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Peritoneal and Retroperitoneal Neoplasm | 10 | Observed | clinicaltrials | graph → |